INTERNATIONAL PATENT: INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FILES APPLICATION FOR "DUT INHIBITION IN HOMOLOGOUS RECOMBINATION DEFICIENCY CANCER"

GENEVA, Sept. 1 -- INSTITUT CURIE (26 rue d'Ulm75005 PARIS), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, Rue de Tolbiac75013 PARIS) filed a patent application (PCT/EP2025/054574) for "DUT INHIBITION IN HOMOLOGOUS RECOMBINATION DEFICIENCY CANCER" on Feb 20, 2025. With publication no. WO/2025/176777, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CECCALDI, Raphael (3 rue de la lancette75012 PARIS), MUSIANI, Daniele (3, impasse Jean Beausire75004 PARIS)

Abstract: The invention relates to methods and p...